Product Program year 2025 Source: CMS Open Payments

GORE PROPATEN Vascular Graft

Device Devices

PDI 00733132605774

Open in the dashboard

General payments

$282,923

967 payments

Research payments

$0

0 payments

Through program year 2025, $282,923 in general payments and $0 in research payments were reported against GORE PROPATEN Vascular Graft (Devices).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $113,986 207
2024 General $20,351 217
2023 General $105,780 200
2022 General $30,969 179
2021 General $11,836 164

Breakdown

Who paid General payments · program years 2021–2025
  1. W. L. Gore & Associates, Inc. $282,923 967 payments
Top recipients General payments · program year 2025
  1. Venita Chandra Vascular Surgery · Palo Alto, CA $17,764 16% · 3 payments
  2. Darren Schneider Vascular Surgery · Philadelphia, PA $15,600 14% · 1 payment
  3. William Gray Interventional Cardiology · Wynnewood, PA $14,740 13% · 1 payment
  4. Ellen Dillavou Vascular Surgery · Raleigh, NC $13,723 12% · 3 payments
  5. Steven Abramowitz Vascular Surgery · Washington, DC $13,200 12% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular Surgery Surgery $78,098 69% · 80 practitioners
  2. Interventional Cardiology Internal Medicine $14,740 13% · 1 practitioner
  3. Diagnostic Radiology Radiology $11,154 10% · 2 practitioners
  4. Nephrology Internal Medicine $3,360 3% · 1 practitioner
  5. Surgery $2,643 2% · 41 practitioners

The top 5 of 21 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Pennsylvania $32,002 28% · 17 recipients
  2. California $17,912 16% · 2 recipients
  3. Florida $15,118 13% · 13 recipients
  4. North Carolina $14,017 12% · 3 recipients
  5. District of Columbia $13,200 12% · 1 recipient

The top 5 of 30 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

967 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record